Practice Management

Top Story

Cost savings from infliximab biosimilars ‘insufficient’ to promote use in US

Cost savings from infliximab biosimilars ‘insufficient’ to promote use in US
January 27, 2020
Feature

Trump’s claim to have ‘saved’ preexisting conditions clashes with record

January 24, 2020
Earlier this month, health care policy suddenly managed to steal some headlines away from impeachment and the ongoing horserace of the 2020 Democratic presidential…
Guest Editorial

Refresh your practice

January 23, 2020
In this guest editorial, Wayne B. Jonas, MD, the executive director of Samueli Integrative Health
Editorial

What’s on Your Shelf? Recommended Reading in the New Year

Healio Rheumatology, January 2020
Leonard H. Calabrese, DO
Over the past few years in this column, I have occasionally shouted out a book I have read and I have occasionally been rewarded by more than a few of my readers then…
More Headlines »